|
|
Untitled Document
SCIENTIFIC PROGRAM
| WEDNESDAY, JUNE 09 |
THURSDAY, JUNE 10 |
FRIDAY, JUNE 11 |
SATURDAY, JUNE 12 |
WEDNESDAY, JUNE 09 |
13.00-16.30 |
REGISTRATION |
Hall 1
SESSION I
Inaugural Lecture |
16.30-17.30 |
OPENING CEREMONY |
Chairperson |
İlkay Küçükgüzel (Marmara University, Turkey) |
17.30-18.30
PL-1 |
The antiviral drug era: Half a century after the synthesis of the first antiviral drug
Erik De Clercq (Rega Institute, Katholieke Universiteit Leuven, Belgium) |
18.30-21.00 |
WELCOME RECEPTION |
THURSDAY, JUNE 10 |
HALL 1
SESSION II
Computational chemistry & molecular modeling |
HALL 2
SESSION III
Natural products & phytotheraphy |
Chairpersons : Sumru Özkırımlı(Istanbul University, Turkey)
Salvatore Guccione (Catania University) |
Chairpersons : Filiz Meriçli (İstanbul University, Turkey) |
09.00-09.40
PL-2 |
Computer aided drug design studies on chemotherapeutically active heterocyclic compounds
Esin Akı (Ankara University, Turkey) |
09.00-09.40
PL-4 |
Scientific evaluation of Turkish folk remedies for wound healing
Erdem Yeşilada (Yeditepe University, Turkey) |
09.40-10.20
PL-3 |
De novo design of selective monoamine oxidase A and B inhibitors : evaluation of novel pyrazoline derivatives using molecular modeling techniques
Kemal Yelekçi (Kadir Has University, Turkey) |
09.40-10.20
PL-5 |
Developing herbal medicines: Can metabolomic approaches help in establishing their quality and safety?
Michael Heinrich (University of London, UK) |
10.20-10.40 |
COFFEE BREAK & EXHIBITION |
HALL 1
SESSION IV
Drug delivery & drug targeting |
HALL 2
SESSION V
Drug safety & personalized medicine |
Chairpersons : Atilla Hıncal (Hacettepe University, Turkey)
Elizabeth Colbourn (Intelligensys Ltd., UK) |
Chairpersons : Gül Dülger (Marmara University, Turkey)
Véronique Michaud (Montréal University, Canada) |
10.40-11.20
PL-6 |
Peptide drug delivery using phospholipid nanomicelles
Hayat Önyüksel (University of Illinois, USA) |
10.40-11.20
PL-9 |
The metabolomics revolution in drug metabolism
Jeffrey R. Idle (Charles University, Czech Republic) |
11.20-12.00
PL-7 |
Advances responsive and feedback-controlled nanoparticles for drug and protein delivery
Nicholas Peppas (University of Texas, USA) |
11.20-12.00
PL-10 |
Pharmacogenetics/genomics for predictiveand personalized medicine in post genomic era
Candan Hızel (Centre Jean Perrin Anti-cancereux-Clermont-frerand, France) |
12.00-12.40
PL-8 |
Brain drug targeting
Yılmaz Çapan (Hacettepe University, Turkey) |
|
|
12.40-14.00 |
LUNCH |
13.00-15.00 |
PROF.DR. MUSTAFA NEVZAT PISAK HALL
Workshop on Pharmaceutical Care in Diabetes
Fikret Vehbi İzzettin, Mesut Sancar, Şule Rabuş, Betül Okuyan |
HALL 1
SESSION VI
Proteins & peptidomimetics for future drugs |
HALL 2
SESSION VII
Pharmacogenetics & cardiovascular disease |
Chairpersons : Güler Yalçın (Marmara University, Turkey),
İsmail Yalçın (Ankara University, Turkey) |
Chairpersons : Semra Şardaş (Marmara University, Turkey),
Jeffrey R. Idle (Charles University, Czech Republic) |
14.00-14.40
PL-11 |
Translating information about biochemical pathways into practical, small organic or peptidomimetic therapeutic agents
Salvatore Guccione (Catania University, Italy) |
14.00-14.40
PL-14 |
Pharmacogenetics and cardiovascular drugs
Jacques Turgeon(Montréal University, Canada) |
14.40-15.20
PL-12 |
Potential protein drugs: New protein K dependent proteins and their receptors
Fikriye Uras (Marmara University, Turkey) |
14.40-15.20
PL-15 |
The influence of pharmacogenetics for warfarine dose requirements
Véronique Michaud (Montréal University, Canada) |
15.20-16.00
PL-13 |
Understanding protein properties: essential for proteomics, quality control, binding assays and molecular modelling
Hermann Wätzig (Technical University Braunschweig, Germany) |
15.20-16.00
OP-1 |
Resistin gene expression in type 2 diabetic patients human adipose tissues: relationship with drug use: relationship with drug use
Belgin Süsleyici Duman (Marmara University, Turkey) |
PROF.DR. MUSTAFA NEVZAT PISAK HALL
Clinical parmacy and pharmaceutical care |
Chairperson: Levent Kabasakal (Marmara University, Turkey) |
15.00-15.20
OP-2 |
The effect of medication compliance on control of chronic diseases
Feras Jassim Jirjees (Sharjah University, UAE) |
15.20-15.40
OP-3 |
Old and new antiarrythmics medications: Current directions
Muneera Albabtain (Prince Sultan Cardiac Center, Saudi Arabia) |
15.40-16.00
OP-4 |
Cardiac rehabilitation: Measures and tools
Fadwa Fadwa (Prince Sultan Cardiac Center, Saudi Arabia) |
Chairperson: Azize Şener (Marmara University, Turkey) |
16.20-16.40
OP-5 |
Some tacrolimus pharmacokinetic properties in Iranian liver transplant recipients.
Simin Dashti - Khavidaki (Tehran University of Medical Sciences, Iran) |
16.40-17.00
OP-6 |
Enhancement of the cytotoxicity of anticancer drugs by celecoxib is cell type-, drug- and sequence-dependent.
Raafat El-Awady (Sharjah University, UAE) |
16.00-16.20 |
COFFEE BREAK & EXHIBITION |
HALL 1
SESSION VIII
The use of ANN in pharmacy research |
HALL 2
SESSION IX
Rational pharmacotherapy teaching in Turkey |
| Chairperson : Betül Dortunç (Marmara University, Turkey) |
Chairperson : Berrak Yeğen (Marmara University, Turkey) |
16.20-17.00
PL-16 |
Machine Learning Technologies in Pharmaceutical Formulation
Elisabeth Colbourn (Intelligensys Ltd., UK) |
16.20-17.00
PL-17 |
PL-17a : Problem based Rational Pharmacotherapy Teaching : An Experience in a Medical School in Turkey
Ersin Yarış (Karadeniz Technical University, Turkey)
PL-17b : Problem based Rational Pharmacotherapy Teaching : An Experience in a Pharmacy School in Turkey
Hale Z. Toklu (Marmara University, Turkey) |
FRIDAY, JUNE 11 |
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION X
Recent developments on antiviral & antituberculosis drug design |
HALL 1
SESSION XI
Oxidative damage & antioxidants |
Chairperson : Dilek Erol (Yeditepe University, Turkey)
|
Chairpersons : Göksel Şener (Marmara University, Turkey),
Fikriye Uras (Marmara University, Turkey) |
09.00-09.40
PL-18 |
Inhibitors of hepatitis C virus replication
Neerja Kaushik – Basu (New Jersey MedicalSchool, USA) |
09.00-09.40
PL-20 |
Melatonin: mechanisms as an antioxidant and clinical applications
Russel J. Reiter (University of Texas, USA) |
09.40-10.20
PL-19 |
Prevention of HIV by means of microbicide formulations. Why does it take so long?
Paul J. Lewi (Janssen Pharmaceutica, Belgium) |
09.40-10.20
PL-21 |
The roles of multidrug resistance transporter (Mdr)-1 and multidrug resistance-associated protein (Mrp)-1 in the treatment of stroke
Ertuğrul Kılıç (Yeditepe University, Turkey) |
10.20-10.40 |
COFFEE BREAK & EXHIBITION |
| 10.00-12.00 |
PROF.DR. MUSTAFA NEVZAT PISAK HALL
Panel on Pharmacoeconomics
Moderator :Erdal Akalın
Speakers : Mehtap Tatar, Aylin Sancar, Ömer Saka, Ali Edizer, Akif Akbulat |
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XII
New frontiers on the treatment of neoplastic diseases |
HALL 1
SESSION XIII
New approaches for drug formulation |
Chairpersons : Rolf W. Hartmann (Saarland University, Germany)
Birsen Tozkoparan (Hacettepe University, Turkey)
|
Chairpersons : Gülgün Yener, (İstanbul University, Turkey)
Yılmaz Çapan (Hacettepe University, Turkey) |
10.40-11.20
PL-22 |
New potent inhibitors of human protein kinase CK2, a target in neoplastic diseases
Joachim Jose (Heinrich Heine University) |
10.40-11.20
PL-24 |
Dry powder inhalers: construction of antibiotic microparticles for lung infection treatment
Paolo Colombo (University of Parma, Italy) |
11.20-12.00
PL-23 |
Molecular Targeted Therapies In Cancer Medicine
Emin Kansu (Hacettepe University, Turkey) |
11.20-12.00
PL-25 |
The role of gamma scintigraphy in pharmaceutical product development
Fiona McInnes (University of Strathclyde, UK) |
12.00-13.30 |
LUNCH |
13.00-13.30 |
POSTER SESSION |
| |
|
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XIV
Neuroscience & antipsychotic targets |
HALL 1
SESSION XV
Biotechnology and Nanotechnology |
| Chairpersons : Kemal Yelekçi (Kadir Has University, Turkey) |
Chairpersons : Jülide Akbuğa (Marmara University, Turkey)
Ahmet Zeki Şengil (Marmara University, Turkey) |
13.30-14.10
PL-26 |
Novel enzymatic pathways in Alzheimer's disease pathogenesis
Domenico Praticò (Temple University, USA) |
13.30-14.10
PL-29 |
Functional macromolecules for drug delivery
Rana Sanyal (Boğaziçi University, Turkey) |
14.10-14.50
PL-27 |
Glutamatergic system and its role in neurobiology of psychiatric disorders
Feyza Arıcıoğlu(Marmara University, Turkey) |
14.10-14.50
PL-30 |
An old material for new applications: Carbon nanotube carriers for drug delivery
İ.Tuncer Değim (Gazi University, Turkey) |
14.50-15.30
PL-28 |
Design and synthesis of selective glutamate receptor agonists
Rasmus P. Clausen (University of Copenhagen, Denmark) |
14.50-15.30
PL-31 |
Human tooth germ stem cells (HTGSCs): A promising stem cell source
Fikrettin Şahin(Yeditepe University, Turkey) |
15.30-15.50 |
COFFEE BREAK & EXHIBITION |
PROF.DR. MUSTAFA NEVZAT PISAK HALL |
Pharmaceutical analysis and formulation
Chairperson : Adnan Aydın (Marmara University, Turkey) |
Drug formulation
Chairperson : Paolo Colombo (University of Parma, Italy) |
13.30-13.50
OP-7 |
Development and validation of an HPLC method for the determination of atorvastatin and its impurities.
Serap Odabaşı (Bilim Pharmaceuticals, Turkey) |
14.30-14.50
OP-10 |
Orally fast disintegrating tablets: Developments, technologies and clinical studies
Tansel Çomoğlu (Ankara University, Turkey) |
13.50-14.10
OP-8 |
A stability-indicating UPLC method for the determination of levofloxacin and its related compounds.
İlkay Küçükgüzel (Marmara University, Turkey) |
14.50-15.10
OP-11 |
Preparation and characterization of vascular endothelial growth factor loaded poly(lactic-co-glycolic acid) microspheres
Oya Sipahigil (Marmara University, Turkey) |
14.10-14.30
OP-9 |
A novel accelerated in vitro release method for biodegradable coating of drug eluting stents: Insight to the drug release mechanisms.
Marika Kamberi (Abbott Vascular Inc., USA) |
16.10-16.30
OP-12 |
Formulation of herbal conditioner shampoo and evaluation it’s physicochemical properties.
Gholamreza Dehghan – Noudeh (Kerman University of Medical Sciences, Iran) |
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XVI
Drug discovery & development |
HALL 1
SESSION XVII
Pharmaceutical care |
| Chairperson : Rasmus P. Clausen (University of Copenhagen, Denmark) |
Chairperson : Türkan Yurdun (Marmara University, Turkey) |
15.50-16.30
PL-32 |
From target identifcation, hit discovery to lead optimisation: recent examples from our research
Rolf W. Hartmann (Saarland University, Germany) |
15.50-16.30
PL-33 |
Development of clinical pharmacy and pharmaceutical Care in Turkey
Fikret Vehbi İzzettin (Marmara University, Turkey) |
| SATURDAY, JUNE 12 |
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XVIII
Novel approaches for cosmetics |
HALL 1
SESSION XIX
Drug metabolism & metabolite-induced toxicity |
Chairpersons : Yıldız Özsoy-Erginer (İstanbul University, Turkey)
Ayla Gürsoy (Marmara University, Turkey) |
Chairpersons : Jacques Turgeon (Montréal University, Canada)
Feyza Arıcıoğlu (Marmara University, Turkey) |
09.00-09.40
PL-34 |
Usage of nanotechnology and biotechnology in cosmetology
Gülgün Yener (İstanbul University, Turkey) |
09.00-09.40
PL-37 |
Toxicity of Mycotoxins
Gülden Z. Omurtag (Marmara University, Turkey) |
09.40-10.20
PL-35 |
What are the novelties in cosmetic science: expectations and responses
Yasemin Yazan (Anadolu University, Turkey) |
09.40-10.20
PL-38 |
In vitro drug metabolism studies : What have we learned from biotransformation of amines ?
Mert Ülgen (Acıbadem University, Turkey) |
10.20-11.00
PL-36 |
Development of dermal and oral products based on tea extracts
Murat Türkoğlu (Marmara University, Turkey) |
10.20-11.00
PL-39 |
Pharmacogenetics is the important component of pharmacovigilance
Semra Şardaş (Marmara University, Turkey) |
11.00-11.20 |
COFFEE BREAK & EXHIBITION |
PROF.DR. MUSTAFA NEVZAT PISAK HALL |
Research on Pharmaceutical Chemistry
Chairpersons : Fatma Gümüş - (Gazi University, Turkey)
Safiye Erdem (Marmara University, Turkey) |
Rational Drug Design
Chairperson : Esin Akı - (Ankara University, Turkey)
Bedia Kaymakçıoğlu (Marmara University, Turkey) |
09.00-09.20
OP-13 |
Synthesis and AChE/BuChE inhibitory and antimicrobial activities of 6-substituted-3(2H)-pyridazinone-2-propyl-3-(substituted/nonsubstituted benzal) hydrazones
Mehtap Gökçe (Gazi University, Turkey)
|
10.00-10.20
OP-16 |
Synthesis and selective inhibitory activity against MAO of 3-substituted benzylidenehydrazine derivatives containing 2-benzoxazolinones and molecular docking studies
Nesrin Gökhan Kelekçi (Hacettepe University, Turkey) |
09.20-09.40
OP-14 |
Synthesis and evaluation of antiviral activity of some novel heterocyclic thiourea compounds
Esra Tatar (Marmara University, Turkey) |
10.20-10.40
OP-17 |
QSAR study of phenylalkylamine derivatives as monoamine oxidase inhibitors
Safiye Erdem (Marmara University, Turkey) |
09.40-10.00
OP-15 |
3,6-Disubstituted 7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines as novel analgesic/anti-inflammatory compounds
Peri Aytaç (Hacettepe University, Turkey) |
10.40-11.00
OP-18 |
Investigation of ligand recognition by beta-lactamases.
Elif Özkırımlı Ölmez (Boğaziçi University, Turkey) |
PROF. DR. MUSTAFA NEVZAT PISAK HALL
|
Diabetes and Cardiovascular Disease
Chairperson: Mesut Sancar (Marmara University, Turkey) |
11.00-11.20
OP-19 |
Diabetes Mellitus management and its implication to cardiovascular disease
Muneera Albabtain (Prince Sultan Cardiac Center, Saudi Arabia) |
11.20-11.40
OP-20 |
Plasma matrix gla protein (mgp) levels in patients with coronary artery disease
Erdem Yılmaz (Marmara University, Turkey) |
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XX |
HALL 1
SESSION XXI |
Chairperson : Emre Dölen (Marmara University, Turkey) |
Chairperson : Fikret Vehbi İzzettin (Marmara University Turkey) |
11.20-12.00
PL-40 |
New materials and technologies for separation of chiral drugs
Bezhan Chankvetadze (Tbilisi State University, Georgia) |
PL-41 |
Gender difference in science
Berrak Yeğen (Marmara University, Turkey) |
12.00-13.30 |
LUNCH |
13.00-13.30 |
POSTER SESSION |
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XXII
Pharmaceutical Industry |
HALL 1
SESSION XXIII
Therapeutic applications of immunology
|
Chairpersons : Fethi Şahin (Gazi University, Turkey) ;
Mert Ülgen (Acıbadem University, Turkey) |
Chairpersons : Fikrettin Şahin (Yeditepe University, Turkey) |
13.30-14.10
PL-42 |
Drug discovery and development
Esen Bellur(Zentiva Pharmaceuticals, API Plant, Turkey) |
13.30-14.10
PL-44 |
Allergen specific immunotheraphy in allergic disease
Tunç Akkoç(Marmara University, Turkey) |
14.10-14.50
PL-43 |
The effects of patent protection in Turkish pharmaceutical industry
Tuncer Arslan(Koçak Pharmaceuticals, Turkey) |
|
|
PROF.DR. MUSTAFA NEVZAT PISAK HALL |
New applications for pharmacy and hospital practice
Chairperson : Şule Apikoğlu Rabuş (Marmara University, Turkey) |
13.10-13.30
OP-21 |
Radiopharmacy applications in hospital practice
Mine Silindir (Hacettepe University, Turkey) |
13.30-13.50
OP-22 |
Fat Mass and Obesity Associated Gene Expression in Human Omental and Subctaneous Adipose Tissue
Meliha Koldemir (Marmara University, Turkey) |
13.50-14.10
OP-23 |
Relationship between eNOS Glu298asp Polymorphism in Acute Coronary Syndrome and Coronary Heart Disease Patients.
Belgin Süsleyici Duman (Marmara University, Turkey) |
14.10-14.30
OP-24 |
Assessment of the 5th grade pharmacy students’ opinions on the first-time held ‘Pharmacy Practice I’ course of the second cycle
Betül Okuyan (Marmara University, Turkey) |
14.30-14.50
OP-25 |
Does Phototherapy Cause Dna Damage in Psoriasis Patients ?
Diren Beyoğlu (Marmara University, Turkey) |
14.50-15.10 |
COFFEE BREAK & EXHIBITION |
15.10-16.00 |
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
CLOSING CEREMONY |
|
|